Clinical Ophthalmology
Volume 17, 2023 - Issue
Open access
267
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH
Biosimilar versus InnovAtor MoLecule of RAnibizumab in Neovascular Age-Related MaCular DEgeneration (The BALANCE Trial): Real-World Evidence
Debdulal Chakraborty1 Department of Vitreoretinal Services, Disha Eye Hospitals, Kolkata, West Bengal, IndiaCorrespondence[email protected]
https://orcid.org/0000-0001-9693-7882
Soumen Mondal1 Department of Vitreoretinal Services, Disha Eye Hospitals, Kolkata, West Bengal, India
, Subhendu Boral1 Department of Vitreoretinal Services, Disha Eye Hospitals, Kolkata, West Bengal, India
, Arnab Das1 Department of Vitreoretinal Services, Disha Eye Hospitals, Kolkata, West Bengal, India
, Tushar Kanti Sinha1 Department of Vitreoretinal Services, Disha Eye Hospitals, Kolkata, West Bengal, India
, Saptorshi Majumdar1 Department of Vitreoretinal Services, Disha Eye Hospitals, Kolkata, West Bengal, India
, Ranabir Bhattacharya2 Department of MIS, Disha Eye Hospitals, Kolkata, West Bengal, India
& Ritobroto Maitra3 Radical Health Tech, New Delhi, India
https://orcid.org/0000-0002-3409-6114
Pages 1067-1076
|
Received 17 Feb 2023, Accepted 28 Mar 2023, Published online: 08 Apr 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.